Actively Recruiting
Proteogenomic Monitoring to Detect Early Kidney Disease, Rejection, and Hepatitis C in Liver Transplant Patients
Led by Northwestern University · Updated on 2026-05-22
1000
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying liver transplant recipients to see if blood, urine, and tissue tests can help detect chronic kidney disease CKD, acute rejection AR, and hepatitis C virus HCV at early stages. These conditions can lower the bodys ability to function properly after a transplant. Detecting them early may help with treatment and reduce the need for repeat organ transplants. The study focuses on new molecular techniques to find sensitive and specific biomarkers that could improve monitoring compared to traditional methods like biopsies or kidney function tests. The study involves collecting samples such as blood and urine from patients who have received liver transplants. Researchers analyze these samples using advanced techniques like DNA microarrays to identify gene expression patterns linked to kidney transplant rejection and injury. This observational research does not involve experimental treatments but aims to develop markers that can be tested in a minimally invasive way to monitor transplant health. The study is led by Northwestern University and has been ongoing since 2010. Participants will provide samples at the time of liver biopsy and possibly other times during their care. The researchers will assess proteogenomic biomarkers related to CKD, AR, and HCV. Data from gene expression profiles in peripheral blood will be used to understand transplant outcomes better. The study plans long-term follow-up through 2031, allowing researchers to track changes over time. Participants must be able to provide informed consent and comply with study procedures during this period.
CONDITIONS
Brief Title
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Research Team
M
Misael Villegas, BA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here